Rituximab

Records for this ingredient, by country (identity only).

ATC L01FA01 · 13 markets · 144 records

Rituximab 13 markets · 144 records Forms
Filters
Kind

GB 29 records · 9 shown of 9 Source NHSBSA dm+d · Data as of 2026-10-19

Only this ingredient

CN 17 records · 4 shown of 4 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

Only this ingredient

  • 100 mg/10 mLinjection汉利康利妥昔单抗生利健、美罗华 also in GB·AU·US
    +3Other 3 marketsFRSGJP
  • 500 mg/50 mLinjection汉利康利妥昔单抗美罗华 also in GB·AU·US
    +3Other 3 marketsFRSGJP
  • 100 mg per mL / per unit basis not statedinjection得利妥利妥昔单抗达伯华
  • 1,400 mg per mL / per unit basis not statedinjectionManufacturer: Roche Pharma(Schweiz) AG

AU 14 records · 5 shown of 5 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

Only this ingredient

  • 100 mg/10 mLinjectionRIXIMYORuxience、Truxima also in GB·CN·US
    +3Other 3 marketsFRSGJP
  • 500 mg/50 mLinjectionRIXIMYORuxience、Truxima also in GB·CN·US
    +3Other 3 marketsFRSGJP
  • 100 mg per mL / per unit basis not statedinjectionRUXIENCE Rituximab 500mg/ 50mL concentrated solution for injection vialTRUXIMA rituximab (rch) 500 mg/ 50 mL concentrate solution for intravenous infusion unknown
  • 500 mg per mL / per unit basis not statedinjectionRUXIENCE Rituximab 500mg/ 50mL concentrated solution for injection vialTRUXIMA rituximab (rch) 500 mg/ 50 mL concentrate solution for intravenous infusion unknown
  • 10 mg/mL per mL / per unit basis not statedinjectionRIXIMYO rituximab (rch) 500mg/50mL concentrated injection vial unknown
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名RIXIMYO ×2Truxima ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

ES 11 records · 4 shown of 4 Source CIMA (AEMPS) · Data as of live

Only this ingredient

  • 100 mg per mL / per unit basis not statedinjectionITUXREDIMABTHERA、RIXATHON、Ruxience、Truxima
  • 500 mg per mL / per unit basis not statedinjectionITUXREDIRIXATHON、Ruxience、Truxima
  • 1,400 mg per mL / per unit basis not statedinjectionMABTHERA SUBCUTANEA
  • 50 mg per mL / per unit basis not statedinjectionMABTHERA

US 10 records · 4 shown of 4 Source openFDA NDC Directory · Data as of 2026-10-23

Only this ingredient

  • 100 mg/10 mLinjectionRiabniRuxience also in GB·CN·AU
    +3Other 3 marketsFRSGJP
  • 500 mg/50 mLinjectionRiabniRuxience also in GB·CN·AU
    +3Other 3 marketsFRSGJP
  • 10 mg per mL / per unit basis not statedinjectionRituxanTruxima

Combination products containing this ingredient

  • 120 mg per mL / per unit basis not statedinjection CombinationHyaluronidase (Human Recombinant) 2,000 unit + Rituximab 120 mgRituxan Hycela

HK 9 records · 0 shown of 0 Source 衞生署藥物辦公室(香港)註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

9 records · 0 manufacturers 9 registros · 0 fabricantes 9 个记录 · 0 个厂家 9 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名MABTHERA CONC FOR SOL FOR INF 100MG/10ML ×4MABTHERA INJ 100MG/10ML ×4MabThera solution for subcutaneous injection ×2Rixathon Concentrate for Solution for Infusion ×6TRUXIMA CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/10ML ×4

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

FR 9 records · 5 shown of 5 Source Base de données publique des médic · Data as of 2026-11-03

Only this ingredient

CA 8 records · 4 shown of 4 Source Health Canada Drug Product Databas · Data as of 2026-10-23

Only this ingredient

  • 10 mg per mL / per unit basis not statedliquidADRUXERituxan、RIXIMYO、Ruxience
  • 119.65812 mg/1 mLliquidRITUXAN SC
  • 119.402985 mg/1 mLliquidRITUXAN SC
  • 10 mg/1 mLliquidTruxima

EU 7 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

7 records · 0 manufacturers 7 registros · 0 fabricantes 7 个记录 · 0 个厂家 7 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Blitzima ×1ITUXREDI ×2MABTHERA ×2RIXATHON ×2RIXIMYO ×2Ruxience ×2Truxima ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

SG 6 records · 4 shown of 4 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

Only this ingredient

TW 6 records · 0 shown of 0 Source 衛生福利部食品藥物管理署(TFDA)全部藥品許可證資料集 · Data as of 2026-10-22 · some records have no stated strength

6 records · 0 manufacturers 6 registros · 0 fabricantes 6 个记录 · 0 个厂家 6 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Mabthera solution for IV Infusion ×1MabThera solution for subcutaneous injection ×2Redditux concentrate for solution for infusion ×1RIABNI Concentrate for Solution for infusion ×2Rixathon Concentrate for Solution for Infusion ×3Truxima ×4妥利希瑪 注射劑 ×2洛希隆注射劑 ×1

and 4 more (0 manufacturers) y 4 más (0 fabricantes) 还有 4 个(0 个厂家) 還有 4 個(0 個廠商)

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

JP 6 records · 2 shown of 2 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

Only this ingredient

MX 2 records · 0 shown of 0 Source COFEPRIS · Data as of annual · some records have no stated strength

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名KREFT ×1XIMA ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.